Literature DB >> 1763399

Hemodynamic monitoring and pulse oximetry during percutaneous gastrostomy and jejunostomy: necessity or nuisance?

E B Morlote1, T N Zweng, W E Strodel.   

Abstract

Hemoglobin desaturation and arrhythmias have been reported during diagnostic gastroscopy and colonoscopy. During endoscopic placement of percutaneous gastrostomy tubes (PEG), the gastroscope is inserted twice and the stomach is markedly distended, thus increasing the potential risk of complications. Also, the procedure is frequently performed in patients exhibiting underlying systemic disease or little respiratory reserve. Patients undergoing PEG or percutaneous endoscopic jejunostomy (PEJ) were studied prospectively. Blood pressure, pulse, pulse oximetry, and lead II ECG tracings were obtained. Measurements were made before sedation, after sedation, at gastroscope insertion, at gastrostomy placement, at gastroscope reinsertion, and at 5 min after the procedure. In all, 50 patients (mean age, 56.8 years; 16 women, 26 men) underwent PEG only (39 cases) or PEG/PEJ (11 cases). The endoscopy suite was the site for the procedure in 38 cases and the intensive care unit was used in 12 cases. The mean time required for PEG and PEG/PEJ was 14.7 +/- 1.1 and 18.9 +/- 2 min, respectively. Blood pressure remained stable throughout the procedure. Sinus tachycardia was observed in 72% of patients. Arterial oxygen saturation decreased after the administration of intravenous sedation but remained constant during the procedure. We reached the following conclusions: (1) desaturation occurs during sedation, (2) saturation remains constant during PEG/PEJ, (3) the mean blood pressure remains constant during PEG/PEJ, and (4) PEG/PEJ are safe procedures and monitoring should be individualized.

Entities:  

Mesh:

Year:  1991        PMID: 1763399     DOI: 10.1007/bf02653219

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  18 in total

Review 1.  Principles of pulse oximetry: theoretical and practical considerations.

Authors:  C M Alexander; L E Teller; J B Gross
Journal:  Anesth Analg       Date:  1989-03       Impact factor: 5.108

2.  Complications of fiberoptic gastrointestinal endoscopy--five years' experience in a central hospital.

Authors:  O Reiertsen; J Skjøtø; C D Jacobsen; A R Rosseland
Journal:  Endoscopy       Date:  1987-01       Impact factor: 10.093

3.  Changes in oxygenation and pulse rate during endoscopy.

Authors:  S R Hayward; C Sugawa; R F Wilson
Journal:  Am Surg       Date:  1989-03       Impact factor: 0.688

4.  Arrhythmias during upper gastrointestinal endoscopy.

Authors:  P K Mathew; F V Ona; K Damevski; W A Wallace
Journal:  Angiology       Date:  1979-12       Impact factor: 3.619

5.  The effect of upper gastrointestinal endoscopy on arterial O2 tension in smokers and nonsmokers with and without premedication.

Authors:  A A Pecora; J C Chiesa; A M Alloy; J Santoro; B Lazarus
Journal:  Gastrointest Endosc       Date:  1984-10       Impact factor: 9.427

6.  The causes of hypoxemia in elderly patients during endoscopy.

Authors:  P Rozen; Z Fireman; T Gilat
Journal:  Gastrointest Endosc       Date:  1982-11       Impact factor: 9.427

7.  Upper intestinal endoscopy induces hypoxemia in patients with obstructive pulmonary disease.

Authors:  P S Rostykus; G B McDonald; R K Albert
Journal:  Gastroenterology       Date:  1980-03       Impact factor: 22.682

8.  Intravenous midazolam for upper gastrointestinal endoscopy: a study of 800 consecutive cases relating dose to age and sex of patient.

Authors:  G D Bell; G P Spickett; P A Reeve; A Morden; R F Logan
Journal:  Br J Clin Pharmacol       Date:  1987-02       Impact factor: 4.335

9.  Cardiovascular responses to upper gastrointestinal endoscopy.

Authors:  E W Bough; S Meyers
Journal:  Am J Gastroenterol       Date:  1978-06       Impact factor: 10.864

10.  Cardiopulmonary risk of esophagogastroduodenoscopy. Role of endoscope diameter and systemic sedation.

Authors:  D A Lieberman; C K Wuerker; R M Katon
Journal:  Gastroenterology       Date:  1985-02       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.